EP2680875
COAGULATION FACTOR-TARGETING TO TLT-1 ON ACTIVATED PLATELETS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
2.3.2012EP published:
23.10.2019EP application number:
12707095.1
EPO information:
European Patent Register
Max expiry date:
1.3.2032
Title:
COAGULATION FACTOR-TARGETING TO TLT-1 ON ACTIVATED PLATELETS
Timeline
Today
2.3.2012EP application
23.10.2019EP Publication
Owner
Name:
Novo Nordisk Health Care AGAddress:
Thurgauerstrasse 36/388050 Zürich, CH
Inventor
Name:
HILDEN, IdaAddress:
Bagsvaerd, DK
Name:
PESCHKE, BerndAddress:
Bagsvaerd, DK
Name:
BREINHOLT, JensAddress:
Bagsvaerd, DK
Name:
KOFOD-HANSEN, MikaelAddress:
Bagsvaerd, DK
Priority
Number:
11156682Date:
2.3.2011Country:
EP
Number:
201161449254 PDate:
4.3.2011Country:
US
Classification
Categories:
A61K 38/36, C07K 14/16, C07K 14/745